Patents
Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780)
04/2003
04/02/2003EP1296931A2 Polyamine analogues as cytotoxic agents
04/02/2003EP1296716A2 New formulation
04/02/2003EP1296687A2 Treatment of male sexual dysfunction
04/02/2003EP1296681A2 Use of microsomal triglyceride transfer protein (mtp) inhibitors for reducing the number of postprandial triglyceride-rich lipoprotein particles (pptrl)
04/02/2003EP1296674A2 Use of substituted indole compounds for increasing nitric oxide synthase activity
04/02/2003EP1121108B1 Novel therapeutic use of compounds with beta-3-agonist activity
04/02/2003EP1019887B1 Fluorescent cyanine dyes
04/02/2003EP1000027B1 Thermodynamically stable modification of 1-(4-carbazolyloxy)-3- 2-(2-methoxyphenoxy)ethylamino]-2-propanole, process for its preparation and pharmaceutical compositions containing it
04/02/2003EP0894089B9 Novel heterocyclic compounds having antidiabetic, hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions containing them
04/02/2003EP0882029B1 Heterocyclic derivatives as antidiabetic and antiobesity agents
04/02/2003EP0587800B1 Immunomodulatory azaspiranes
04/02/2003CN1407053A Blue light emitting compound and electroluminescert device with it as color display substance
04/02/2003CN1406937A 1-[1-(hetero) aryl-1-perhydroxyalkylmethyl]-piperazine compound, preparation thereof and pharmaceutics containing it
04/02/2003CN1104435C Process for the preparation of N-[(l-nButyl-4-piperidyl) methyl-3, 4-dihydro-2h-[1,3] oxazino [3,2-2] indole-10-carboxamide and salts and intermediates in the process
04/01/2003US6541669 Multibinding amine compounds which are beta 2 adrenergic receptor agonists useful in treatment and prevention of respiratory diseases such as asthma, bronchitis
04/01/2003US6541644 Adsorption by polymer; elution, desorption
04/01/2003US6541643 Process for the preparation of spiro[cis-4-(β-hydroxyethyloxy)cyclohexane-[3h]indol]-2′[1′H]one derivatives
04/01/2003US6541507 Notably 4,6-dimethoxyindole-2-carboxylic acid and derivatives thereof
04/01/2003US6541506 Enediyne carboxylated on one end and having a pyrrole, furan or thiophene ring on the other; may be isolated from annarrhinum bellidofolium
04/01/2003US6541505 Inhibiting the activity of Factor Xa; treating a disease state associated with a physiologically detrimental excess amount of thrombin.
04/01/2003US6541503 Substituted oxindole derivatives as protein tyrosine kinase and as protein serine/threonine kinase inhibitors
04/01/2003US6541477 Inhibitors of p38-a kinase
04/01/2003US6541474 Administering a pharmaceutically effective dose of the heterocycle-containing carboxylic acid derivative or salt to a patient suffering form acute promyelocytic leukemia
04/01/2003US6541473 Resorcinol derivatives
03/2003
03/27/2003WO2003025017A1 Cytokine receptor
03/27/2003WO2003024933A1 2-phenyl-3-heteroarylpropionic acid derivative or salt thereof and medicine containing the same
03/27/2003WO2003024923A1 Sulfonamide compounds as protease inhibitors
03/27/2003WO2003024899A2 CYCLIC HYDROXAMIC ACIDS AS INHIBITORS OF MATRIX METALLOPROTEINASES AND/OR TNF-α CONVERTING ENZYME (TACE)
03/27/2003WO2003024448A2 Inhibitors of histone deacetylase
03/27/2003WO2002094263A3 Caspase inhibitors and uses thereof
03/27/2003WO2002060859A3 Cyclic derivatives as modulators of chemokine receptor activity
03/27/2003WO2002014261A3 4-substituted d-glutamic acid derivatives for use as antibiotic
03/27/2003WO2001092218A3 Polyamine analogues as therapeutic and diagnostic agents
03/27/2003US20030060635 Methods of using bis-indolylquinones
03/27/2003US20030060498 5-arylsulfonyl indoles useful for treating disease
03/27/2003US20030060497 Use of indole Mannich bases in the production of medicaments that are used to treat pain
03/27/2003US20030060465 Such as 1-(p-chlorobenzoyl)-5-methoxy-2-methylindole-3-acetic acid morpholinocarbonyloxyethyl ester; for reducing gastrointestinal side effects
03/27/2003US20030060461 Cyclic diamine compound with condensed-ring groups
03/27/2003US20030060459 Diamines as modulators of chemokine receptor activity
03/27/2003CA2465978A1 Inhibitors of histone deacetylase
03/27/2003CA2460151A1 Cytokine receptor
03/27/2003CA2460149A1 2-phenyl-3-heteroarylpropionic acid derivative or salt thereof and medicine containing the same
03/26/2003EP1296142A2 Calcium receptor active molecules
03/26/2003EP1295867A1 Biphenyl compound
03/26/2003EP1294823A1 Double-spiro organic compounds and electroluminescent devices
03/26/2003EP1294718A2 6,5-fused bicyclic heterocycles
03/26/2003EP1294713A2 Compounds possessing antibacterial, antifungal or antitumor activity
03/26/2003EP1294695A2 Substituted diamide derivatives useful as motilin antagonists
03/26/2003EP1294691A1 Serine protease inhibitors
03/26/2003EP1294689A1 Novel $g(b crystalline form of perindopril tert-butylamine salt, preparation method, and pharmaceutical compositions containing same
03/26/2003EP1294688A2 Indolinone derivatives as protein kinase/phosphatase inhibitors
03/26/2003EP1294687A2 1,2,4-trisubstituted benzenes as inhibitors of 15-lipoxygenase
03/26/2003EP1294686A2 Indole derivatives and their use as 15-lipoxygenase inhibitors
03/26/2003EP1294366A1 Pharmaceutical compounds for treating copd
03/26/2003EP1294364A1 Stable gabapentin having ph within a controlled range
03/26/2003EP1159269B1 Anti-imflammatory indole derivatives
03/26/2003EP0885186B1 Amino acid derivatives, pharmaceutical compositions containing these compounds and processes for preparing them
03/26/2003EP0763026B1 Gastrin and cck antagonists
03/26/2003CN1406223A Protease inhibitor and their pharmaceutical uses
03/26/2003CN1103756C Estrogenic agents
03/25/2003WO2003000254A1 Fused cyclic compounds and medicinal use thereof
03/25/2003US6538038 A method of treating a warm-blooded animal having a vascular proliferative disorder, comprising administering, to the animal, an amount of a prodrug of a tubulin binding agent, other than combretastatin A4 disodium phosphate to achieve
03/25/2003US6538003 Pyridopyranoazepine derivatives, their preparation and their therapeutic application
03/25/2003US6537330 Colorants
03/25/2003CA2423800A1 Fused cyclic compounds and medicinal use thereof
03/21/2003WO2002022555A1 Substituted biphenyl derivatives, method for preparing same and pharmaceutical compositions containing same
03/20/2003WO2003022816A1 Process for the preparation of base-free carbazolide anions
03/20/2003WO2003022815A1 3-(4,5,6,7-tetrahydroindol-2-ylmethylidiene)-2-indolinone derivatives as kinase inhibitors
03/20/2003WO2003022814A1 Indole derivatives
03/20/2003WO2003022813A1 Indole derivatives, process for producing the same and drugs containing the same as the active ingredient
03/20/2003WO2003022810A1 3-amino carbonyl-substituted benzoylcyclohexanediones that can be used as herbicides
03/20/2003WO2003022806A2 Cbi analogues of cc-1065 and the duocarmycins
03/20/2003WO2003022280A2 3-glyoxlylamideindoles for treating cancer
03/20/2003WO2003022277A1 Arylsulfonamide derivatives for use as ccr3 antagonists in the treatment of inflammatory and immunological disorders
03/20/2003WO2003022272A1 Appetite-stimulating agents and remedies for anorexia
03/20/2003WO2003004466A3 Dye-sulfenates for dual phototherapy
03/20/2003WO2002100845A8 Hv protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis
03/20/2003WO2002067865A3 N-(aryl)-2-arylethenesulfonamides and therapeutic uses thereof
03/20/2003US20030055109 Stability
03/20/2003US20030055093 For therapy of cardiovascular diseases, stable or unstable angina pectoris, coronary heart disease, stable or unstable angina pectoris, coronary heart disease, Prinzmetal angina, acute coronary syndrome, heart failure, myocardial infarction
03/20/2003US20030055086 Amino acid derivatives and use thereof as nep, ace and ece inhibitors
03/20/2003US20030055077 Method and compositions for the treatment of allergic conditions using pgd2 receptor antagonists
03/20/2003US20030055076 Novel compounds, their preparation and use
03/20/2003US20030055037 Benzimidazole and indole derivatives as CRF receptor modulators
03/20/2003CA2460347A1 3-glyoxlylamideindoles for treating cancer
03/20/2003CA2459879A1 3-(4,5,6,7-tetrahydroindol-2-ylmethylidiene)-2-indolinone derivatives as kinase inhibitors
03/20/2003CA2459515A1 Indole derivatives
03/20/2003CA2459308A1 Cbi analogues of cc-1065 and the duocarmycins
03/19/2003EP1293506A1 New 1-(1-(Hetero)aryl-1-perhydroxyalkylmethyl)-Piperazine derivatives, process for their preparation and pharmaceutical compositions containing the same
03/19/2003EP1292574A1 3-azabicyclo[3.1.0]hexane derivatives having opioid receptor affinity
03/19/2003EP1292564A2 Aminoalcohol derivatives
03/19/2003EP1037637B1 Use of 5ht1a receptor antagonists for preventing and/or treating temporal lobe epilepsy
03/19/2003EP1012131B1 Enantioselective reduction of ketones with a silane agent/metal compound/chiral ligand system
03/19/2003CN1404479A Novel 1,3-dihydro-2H-indol-2-one derivatives their preparing method and the pharmceutical composition containing the same
03/19/2003CN1404477A 哌嗪和哌啶衍生物 Piperazine and piperidine derivatives
03/19/2003CN1403455A Synthesis of 2-oxazolidone derivate by one still process
03/18/2003US6534660 CC-1065 analog synthesis
03/18/2003US6534651 Substituted isoindolinone derivatives
03/18/2003US6534650 Benzisoxazole and 4-amidino-3-hydroxyphenyl chemical intermediates
03/18/2003US6534627 Synthesis and use of amino acid fluorides as peptide coupling reagents